Douglas Gazarian Selected Research

2-aminoethanethiosulfonic acid

1/2017	Inclusion/exclusion criteria in late life depression antidepressant efficacy trials.
12/2016	The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years.
1/2016	Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas Gazarian Research Topics

Disease

2	Bipolar Disorder (Manic Depressive Psychosis) 01/2017 - 12/2016
2	Substance-Related Disorders (Drug Abuse) 01/2017 - 01/2016
1	Cognitive Dysfunction 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Borderline Personality Disorder (Personality Disorders, Borderline) 12/2016
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2016
1	Major Depressive Disorder (Major Depressive Disorders) 01/2016
1	Mental Disorders (Mental Disorder) 01/2016

Drug/Important Bio-Agent (IBA)

3	2-aminoethanethiosulfonic acidIBA 01/2017 - 01/2016
2	Antidepressive Agents (Antidepressants)IBA 12/2016 - 01/2016
1	VortioxetineIBA 01/2016
1	beta-Aminoethyl Isothiourea (AET)IBA 01/2016